Study of Histrelin Subdermal Implant in Patients With Prostate Cancer
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
This trial was an open-label, multi-national, randomized, parallel treatment, active-control
multicenter study in adult males with documented metastatic prostate cancer disease who were
judged to be candidates for hormone therapy.